MAPT and Cognitive impairment: The addition of risk variables, hippocampal volume and CSF biomarkers reflecting brain amyloidosis (Aβ1–42) and tau pathology (pTau181) did not attenuate this result; however, the addition of the RBANS total index score or attention index score did attenuate this result, suggesting that this is part of a global cognitive deficit in the participants with diabetes.